TrialThe international journal of neuropsychopharmacology2020

A Randomized Controlled Trial of Intranasal Neuropeptide Y in Patients With Major Depressive Disorder.

Aleksander A Mathé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.